As for miR-155, scientists have proven that restoration of miR-155 represses the growth of NSCLC malignant cells in the epidermal growth factor receptor mutant, which can serve as reasonable explanation for miR-155 as a NSCLC biomarker at present [33,34]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.